πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 912 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7947289

Multimeric protein toxins to target cells having multiple identifying characteristics

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906104

Methods for detecting pancreatic beta-islet cells and diseases thereof

The Regents of the University of California Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884178

Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nu

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7883892

Swine multipotent adult progenitor cells

Regents of the University of Minnesota Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7871620

Immunoliposomes that optimize internationalization into target cells

The Regents of the University of California Β· Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7850961

Methods for targeting solid tumor stem cells in a solid tumor using a notch4 receptor anta

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7838289

Assay utilizing multipotent adult stem cells

Regents of the University of Minnesota Β· Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7820634

Composition and method for production of transformed cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7807458

Multilineage-inducible cells and uses thereof

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7803558

Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in Schlemm'

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7781413

SEMA3B inhibits tumor growth and induces apoptosis in cancer cells

The Board of Regents of the University of Texas System Β· Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7781565

Compositions and methods related to profiling a plurality of cells based on peptide bindin

The Board of Regents of the University of Texas System Β· Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7777019

Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776607

Mammalian selenoprotein differentially expressed in tumor cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776593

Hes6 as a marker of pancreatic endocrine cells

The Regents of the University of California Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7745144

Peptides and their utility in modulation of behavior of cells expressing Ξ±3Ξ²1 integrins

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7727534

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723311

Delivery of bioactive substances to target cells

United States of America as represented by the Secretary of the Air Force Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7722862

Regulatory T cells suppress autoimmunity

The Regents of the University of California Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7718196

Rapamycin-resistant T cells and therapeutic uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7713710

Isolation and use of solid tumor stem cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7666411

Methods of treating and preventing colitis involving IL-13 and NK-T cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7658923

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing C

The Board of Regents of the University of Texas System Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7659118

Multipotent adult stem cells

Regents of the University of Minnesota Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted